Ignite Plasma

ignite plasma

A minimally invasive surgical platform against pancreatic and biliary tract cancers using cold atmospheric PLASMA

LATEST NEWS

Ignite Plasma at ICPIG 2025

As part of the Ignite Plasma representation at the International Conference on Phenomena in Ionized Gases, ICPIG 2025, Konstantinos Giotis presented our latest progress on our innovative platform development.

Learn More

Ignite Plasma Presents Research at COST Action PlasTHER Final Meeting

Ignite Plasma participated in the Plaster Cost Action meeting in June 2025, where our consortium partner Sorbonne University represented our research in cold atmospheric plasma therapy.

Learn More

4TH TRAINING SCHOOL “BRIDGING SCIENCE AND INNOVATION: TRANSLATING PLASMA MEDICINE ...

One of our team members, George Vafakos, had the opportunity to attend the 4th Training School “Bridging Science and Innovation: Translating Plasma Medicine into Clinic and to the Market” of ...

Learn More

FEATURED ARTWORK

Based on the paper: Personalised in silico biomechanical modelling towards the optimisation of high dose-rate brachytherapy planning and treatment against prostate cancer published in Frontiers in Physiology

Learn More

Computational modelling (also known as 'in silico' modelling) together with ...

Announcement via social media by Vasileios Vavourakis I think we can proudly say that computational modelling (also known as 'in silico' modelling) together with medical image analysis holds great potential helping clinicians ...

Learn More
1/1

Overview

Pancreatic cancer is one of the deadliest cancers as it is detected in late stages and with very few effective treatments available to patients. The IgnitePLASMA project will develop a new solution using cutting-edge technology in plasma physics, computational (in silico) modeling and pancreatic and biliary cancer biology. It will combine multiscale simulations and intelligent systems in plasma control, while taking input from preoperative diagnostics to train the models to determine the appropriate conditions for treatment. The developed technology will be demonstrated through in vivo biological experiments, and this project will lay the foundation for clinical trials in the treatment of pancreatic and biliary tract cancer.

The University of Cyprus announces the launch of the European project for research in the field of computational engineering, plasma physics and cancer treatment research, entitled “A minimally Invasive surgical platform aGainst pancreatic and biliary Tract cancErs using cold atmospheric PLASMA” and acronym : IgnitePLASMA. The research project will be funded for four years by the European Innovation Council and UK Research and Innovation, with a total cost of 3m. euro . The project is a joint venture between the Sorbonne University, the University of Patras, Synnous Ltd from the UK, the Bank of Cyprus Oncology Center and the University of Cyprus which coordinates the project led by Dr Vasileios Vavourakis (Department of Mechanical Engineering). The kick-off meeting for the project took place at the Sorbonne University, Paris on 4-5 April 2024.

Ignite Plasma

CONSORTIUM PARTNERS
CYPRUS UNIVERSITY

The University of Cyprus (UCY) is a public research institute and is the leading academic organisation in Cyprus, with active participation in national, European (HE, H2020, ERC,etc.) and international programmes in R&D and innovation activities. UCY is an endorser of the “European Charter for Researchers” and accredited with the “HR Excellence in Research” logo. The In Silico Modelling Group (ISMG; https://in-silico-modelling.ucy.ac.cy) and the Electromagnetics & Novel Applications Lab (ENAL; https://www.ucy.ac.cy/enalab) from the Mechanical & Manufacturing Engineering (MME) and the Electrical & Computer Engineering (ECE) departments respectively team up and lead this project, IgnitePLASMA. The groups have considerable experience in computer and mathematical modelling, numerical methods and simulations, in high-performance computing and medical image analysis methods.

SORBONNE Université

Sorbonne University (SU) is a multidisciplinary, research-intensive, world-class university. Located in the heart of Paris, with a regional presence, it is committed to the success of its students and to meeting the scientific challenges of the 21st century. Thanks to its 55,300 students, 6,400 academic researchers and partner researchers, and 3,600 administrative and technical staff, Sorbonne University promotes diversity, sustainability, innovation and openness to the world. In cooperation with its partners, it creatively fulfils its missions of teaching, research, innovation, mediation and technology transfer for the benefit of the common good. It ambitiously pursues its public service mission and dedicates itself to the creation and development of knowledge, at the heart and at the intersection of disciplines.

PATRAS UNIVERSITY

The University of Patras is the third largest University in Greece in terms of students, faculty members, administrative personnel, number of departments and degrees awarded. The campus of the University of Patras hosts about 40,000 employees and under- and post-graduate students. It includes 35 Departments covering a wide range of disciplines (Natural Sciences, Engineering, Health Sciences, Humanities and Social Sciences, Economics and Business, etc.), 161 laboratories and 17 fully equipped clinics. In the frame of the project PlasmaIgnite, the University of Patras will design, fully develop and characterize the plasma-based surgical platform (hardware and software) for the application of optimised and real-time adaptable treatment of cancer.

SYNNOUS

Synnous is a full service software product development and engineering company operating from London and Athens, specializing in health and medical technology.
We are a team of experienced product designers, software developers and data scientists with deep knowledge in agile fast track development in mobile and web services.

THE BANK OF CYPRUS ONCOLOGY CENTER

The Bank of Cyprus Oncology Center (BOCOC) is a not-for-profit tertiary Stand-alone Cancer Centre, based in Nicosia, Cyprus. Today, approximately 70% of new cancer cases on the island are treated at BOCOC while over 51,000 patients have visited the Centre since its inception back in 1998. BOCOC will be contributing to the developments described in WP2 and WP3 as part of the IngitePLASMA project.

News

Ignite Plasma at ICPIG 2025

The conference proved to be an incredibly rewarding experience, with our work receiving outstanding feedback from the plasma physics community, particularly highlighting: ✨ Our Key Innovations: ✅ Novel closed-loop systems...

Read More

Ignite Plasma Presents Research

Research Objectives To address this challenge, the research focuses on identifying the RONS that can penetrate biological barriers and determining the physical parameters able to modulate them. The team is...

Read More

Final Meeting COST Action PlasTHER

ORGANIZER COST – EUROPEAN COOPERATION IN SCIENCE AND TECHNOLOGY   This Action is concerned with the medical and biomedical applications of cold atmospheric plasmas. The main aim of the PlasTHER...

Read More